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ABSTRACT The TATA-box binding protein (TBP) is required by eukaryotic RNA polymerases to bind to the TATA box, an
eight-basepair DNA promoter element, to initiate transcription. Carcinogen adducts that bind to the TATA box can hamper this
important process. Benzo[a]pyrene (BP) is a representative chemical carcinogen that can be metabolically converted to highly
reactive benzo[a]pyrene diol epoxides (BPDE), which in turn can form chemically stereoisomeric BP-DNA adducts. Depending
on the TATA-bound adduct’s location and stereochemistry, TATA/TBP binding can be decreased or increased. Our previous
study interpreted the location-dependent effect in terms of conformational freedom and major-groove space available to BP.
Here we further explore speciﬁc structural changes of the TATA/TBP complex to help interpret the stereochemical effect in
terms of the ﬂexibility of the TATA bases that frame the intercalated adduct. Thermodynamic analyses using molecular
mechanics Poisson-Boltzmann surface area (MM-PBSA) yield large standard deviations, which make the computed binding
free energies the same within the error bars and point to current limitations of free energy calculations of large and highly
charged systems like DNA/protein complexes.
INTRODUCTION
Transcription in eukaryotes involves a large range of RNA
polymerases, transcription factors, and other agents (1–3).
The TATA-box binding protein (TBP), a component of
transcription factor II D, is required by all eukaryotic RNA
polymerases for correct initiation of transcription of ribo-
somal, messenger, small nuclear, and transfer RNAs (4). TBP
has a phylogenically conserved 180-residue core segment,
which contains two imperfect direct repeats and supports the
protein’s biological activities. Upon binding to the TATA
box—an A/T-rich 8-basepair (bp) DNA in the DNA pro-
moter region (5)—TBP causes local compaction of the TATA
box, unwinding, and severe bending, which in turn results in
a widened minor groove and a compressed major groove (6)
(see Fig. 1). Speciﬁcally, TBP’s two phenylalanines insert
into the ﬁrst and last base steps of the TATA box, kinking the
DNA locally by 52 and 39, respectively (6). The kinks are
accompanied by another pair of phenylalanines, which form
extensive van der Waals contacts with the second and
seventh basepairs of the TATA box.
Our previous molecular dynamics (MD) study (7) showed
that 12 hydrogen bonds form between TBP and the central
two basepairs of the TATA box and another seven between
TBP and the backbone of the rest of the TATA box residues
(including two strong interactions at the two ends). Inge-
niously, these hydrogen bonds and extensive hydrophobic
interactions stabilize the complex’s kinks as well as the
TATA/TBP binding (see hydrogen bond contribution in (8)),
therefore allowing the normal Watson-Crick basepairings to
be maintained, despite the severely bent TATA DNA.
The TATA/TBP binding and transcription initiation can
be affected if the TATA box is damaged by chemical carcin-
ogens. For example, DNA is often affected by benzo[a]
pyrene (BP), a chemical carcinogen in the class of polycyclic
aromatic hydrocarbons that is a ubiquitous component of
environmental pollutants, like automobile exhaust, tobacco
smoke, and food contaminants (9–11). BP can be metabol-
ically activated to highly reactive benzo[a]pyrene diol
epoxide (BPDE) molecules, which in turn can form BP-
DNA adducts (12). If unrepaired by cellular DNA repairing
machinery, these adducts can lead to transcription blocking
(13,14) or to carcinogenic mutations if bypassed (9,15–19).
BPDE has two enantiomers (Fig. 1): (1)-(7R,8S,9S,10R)-
7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyr-
ene and ()-(7S,8R,9R,10S)-7,8-dihydroxy-9,10-epoxy-7,8,9,
10-tetrahydrobenzo[a]pyrene. They can react with adenines
in DNA to form stereoisomeric 10S(1) and 10R()-trans-
anti-(BP)N6-dA covalent DNA adducts, respectively (9,20–
22). High-resolution NMR solution studies (23–26) show
that BP has conformational preferences in these two adducts:
it is classically intercalated between DNA basepairs, instead
of being exposed in the solvent-accessible major or minor
groove of the DNA duplex (thus, the hydrophobic pyrenyl
moiety of BP can be buried within the duplex). BP resides on
the 39-side of the modiﬁed adenine in the 10S(1) adduct and
on the 59-side in the 10R() adduct.
An experimental study by Rechkoblit and co-workers (27)
has shown that the TATA/TBP binding afﬁnity can be
decreased or slightly increased (Table 1) by the BP-adenine
adducts in the TATA box, depending on the adduct location
(A1 or A2) and stereochemistry (10S(1) or 10R()), as
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shown in Fig. 1. The combination of the adduct location and
stereochemistry leads to four systems studied by the exper-
imental work: 10S(1)-trans-(A1), 10R()-trans-(A1), 10S(1)-
trans-(A2), and 10R()-trans-(A2). The ﬁrst two systems
(BP at A1) were found to increase slightly the TATA/TBP
binding afﬁnity, while the other two (BP at A2) decrease the
binding afﬁnity (Table 1). The adduct stereochemistry plays
a minor role for changing the binding afﬁnity; the 10R()
stereoisomer at both locations shows stronger TATA/TBP
binding afﬁnity than the 10S(1) stereoisomer.
Our previous MD simulation study (7) interpreted the
effect of the adduct location on TATA/TBP binding in terms
of the conformational freedom and major-groove space avail-
able to BP due to the hydrogen bonds and phenylalanine
insertions at the TATA/TBP interface. That is, we found that
BP at A1 can easily adopt an intercalated orientation between
DNA bases or a major-groove orientation in the DNA major
groove without much distortion of the TATA or TBP
backbone; on the other hand, the A2 location does not allow
BP to easily adopt either orientation without distorting the
backbones.
Here we further study the effect of the adduct location on
TATA/TBP binding by examining the adduct-dependent
structural changes of the TATA/TBP complex.We also inter-
pret the effect of the adduct stereochemistry on TATA/TBP
binding. To derive the thermodynamic effects of BP mod-
iﬁcations and to correlate the TATA/TBP complex’s struc-
tural changes with energetics, we perform free energy
analyses on all systems.
METHODS
Initial structures
With InsightII (Accelrys, San Diego, CA), we construct the initial TATA/
TBP/BP structure by combining the crystal structure of TATA/TBP complex
(Protein DataBank ID: 1CDW) (6) and the NMR structure of a BP-modiﬁed
DNA structure (PDB ID: 1AGU) (26). The TATA DNA has the same length
TABLE 1 Experimental equilibrium constants K and binding
free energies DG of TBP bound to BP-modiﬁed
and unmodiﬁed TATA DNA duplexes
TATA DNA K DG (kcal/mol) DDG (kcal/mol)
Unmodiﬁed 1.18 3 108 10.23 0.00
10S(1)-trans-(A1) 1.33 3 10
8 10.30 0.07
10R()-trans-(A1) 1.82 3 108 10.47 0.24
10S(1)-trans-(A2) 5.71 3 10
7 9.84 0.39
10R()-trans-(A2) 8.00 3 107 10.02 0.21
K and DG are derived from Rechkoblit et al. (27). DDG is the relative
binding free energy of a BP-modiﬁed system compared to the unmodiﬁed
one. Experimental temperature is 277.15 K.
FIGURE 1 TATA/TBP/BP complex.
(A) Complex of TBP (red) bound to a BP-
modiﬁed 16-bp TATA DNA (blue and
green) after a 2.32-ns molecular dynam-
ics simulation. The BP-adenine adduct is
pink (spaceﬁlling view) and is positioned
at site A1. (B) TATA box, in the center
of the TATA DNA, is shown with the A1
and A2 BP-adenine adduct locations.
(C) Stereoisomeric BP-adenine adducts:
10S(1)-trans-anti-(BP)-N6-dA (left) and
10R()-trans-anti-(BP)-N6-dA (right).
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(16 bp) as that in the 1CDW PDB structure, but the initial structure is
remodeled to match the experimental sequence (see below; the TATA box is
underlined). Sequence remodeling is conducted on the DNA bases only (not
on sugars or backbone) and causes only one contact change between the
DNA and TBP, as shown in Appendix S1 in the Supplementary Material.
The remodeled structure contains 32 DNA residues (#1–32) and 179 TBP
residues (#33–211) with the BP covalently binding to the DNA.
For each combination of the adduct location (A1 or A2) and stereochem-
istry (10S(1) or 10R()), we determine the best orientation of the adduct in
its TATA/TBP/BP complex structure based on its four low-energy domains
(I, II, III, and IV; see Table 2) (28). These domains, deﬁned by the three
torsion angles in Fig. 1, account for the conformational preferences of the
two stereoisomeric adducts: BP is classically intercalated and residing on the
39-side of the modiﬁed adenine in the 10S(1) adduct and on the 59-side in
the 10R() stereoisomer. The best orientation we ﬁnd produces the minimal
steric collision between the adduct and the TATA/TBP complex.
A total of 11 initial structures of BP-modiﬁed TATA/TBP complexes are
constructed; an unmodiﬁed complex is used as reference. In total, the 12
starting structures are listed in Table 3 (see also Fig. 3 and Table 5 of Zhang
et al. (7)) along with their BP-adenine adduct’s domains (I, II, III, or IV) and
BP’s orientations (intercalated between DNA bases or exposed to DNA
major groove). The initial structure of free TBP is then taken from the PDB
structure of the TBP-DNA complex, by removing the DNA, and then
removing the crystal water molecules that are more than 10 A˚ away from
TBP. The remaining water molecules are retained as they may be important
for TBP. The initial structure of each free TATA DNA is taken from its
corresponding TATA/TBP complex structure by removing TBP, counter-
ions, and water molecules after the complex has been minimized with a
water box and counterions (see Energy Minimization and MD Simulation,
below). Therefore, totally 25 systems are simulated, including 12 TATA/
TBP complexes, 12 free TATA DNA, and one free TBP (Table 3), as
required for the thermodynamic analyses.
Force ﬁeld
The force-ﬁeld parameters of the TATA DNA and the TBP protein are
assigned using the Cornell et al. (29) force ﬁeld with parm98 parameter set
(30). The missing partial charges and three bond angles of the BP-adenine
adducts are computed using our partial charge protocol (see Appendix),
based on the RESP approach (31–33) in AMBER (34), and according to
chemically similar bond angles in the parm98; these computed force-ﬁeld
parameters are listed in Appendix S2 in the Supplementary Material.
Energy minimization and MD simulation
Energy minimization and MD simulations were performed in AMBER 6
(34). Energy minimization eliminates unfavorable van der Waals contacts in
the initial structures. Each system is then solvated with a rectangular box of
TIP3 water molecules (35) and counterions (neutralizing the system and
reproducing the experimental ionic strength). Energy minimization is
performed again to eliminate van der Waals collisions due to the addition of
water molecules and counterions. MD simulations then follow with four
equilibration stages (heating, constant pressure I, constant pressure II, ﬁnal
equilibration) and one production dynamics stage (7). Equilibration focuses
on the solvent while production dynamics collects structural changes of the
solute. The simulations employ the leap-frog Verlet algorithm (36) with a
time step of 2 fs. Electrostatic interactions are computed using the particle-
mesh Ewald method (37,38).
For each of the 12 TATA/TBP systems, energy minimization on the
initial structure is performed with 400 steps of steepest descent (SD)
followed by 400 steps of conjugate gradient (CG). The system is then
solvated with a rectangular box of TIP3 water molecules that extends 10.0 A˚
from the solute and contains 37 Na1 and 23 Cl for neutralizing the system
and mimicking the experimental ionic strength of 130 mM. To relax the
added solvent, the entire system is minimized again using 50 steps of SD
followed by 5000 steps of CG. The four equilibration stages take 460,000
steps (920 ps) and the production dynamics stage takes 700,000 steps
(1400 ps); the total length of the trajectory is then 2.32 ns. More details of
the energy minimization and MD simulation of the 12 TATA/TBP systems
are described in Zhang et al. (7).
For the free TBP, a water box is added with a buffer size of (12.0, 10.0,
10.0) A˚. The buffer size in the X direction is larger than those in the Y and Z
directions because TBP may expand in this direction without bound DNA.
Then 14 Na1 and 30 Cl are added to neutralize the system and satisfy the
experimental ionic strength (130 mM). The free TBP system undergoes the
same procedure of minimizations and dynamics as those TATA/TBP sys-
tems (7) and has a trajectory length of 2.32 ns too.
For the 12 corresponding free TATA DNA systems, each DNA is taken
from its corresponding TATA/TBP complex after the complex is minimized
with a water box and counterions. The TBP, counterions, and all water
molecules are then removed. Each DNA is minimized using 400 steps of SD
followed by 400 steps of CGwith a 1.0 kcal/mol restraint on the DNA’s non-
end atoms. A water box is added with a buffer size of (10.0, 15.0, and 10.0) A˚.
TABLE 2 Low-energy conformational domains of 10S(1) and 10R()-trans-anti-(BP)-N6-dA adducts
Domain x () (O49-C19-N9-C4) a9 () (N1-C6-N6-C10(BP))
b9 () (C6-N6-C10(BP)-C9(BP))
(1) adduct () adduct
I 0–60 0 6 35 90 6 40 90 6 40
II 180–360 0 6 35 90 6 40 90 6 40
III 180–360 180 6 35 90 6 40 90 6 40
IV 0–60 180 6 35 90 6 40 90 6 40
TABLE 3 Simulated systems and simulation lengths
12 TATA/TBP complexes
(2.32 ns each)
12 free TATA DNA
(3.34 ns each)
1 free TBP
(2.32 ns)
Unmodiﬁed Unmodiﬁed
10S(1)-trans-(A1): II (int*) 10S(1)-trans-(A1): II
10S(1)-trans-(A1): III (MG
y) 10S(1)-trans-(A1): III
10R()-trans-(A1): II (MGy) 10R()-trans-(A1): II
10R()-trans-(A1): III (int*) 10R()-trans-(A1): III
10R()-trans-(A1): IV (MGy) 10R()-trans-(A1): IV Free TBP
10S(1)-trans-(A2): III (int*) 10S(1)-trans-(A2): III
10S(1)-trans-(A2): III-2
z (MGy) 10S(1)-trans-(A2): III-2
10S(1)-trans-(A2): IV (int*) 10S(1)-trans-(A2): IV
10R()-trans-(A2): I (MGy) 10R()-trans-(A2): I
10R()-trans-(A2): III (int*) 10R()-trans-(A2): III
10R()-trans-(A2): IV (MGy) 10R()-trans-(A2): IV
*BP is initially intercalated between DNA bases.
yBP is initially exposed to DNA major groove.
zThe second possible conformation of this adduct in domain III.
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The larger buffer in the Y direction allows for the possibility that the bent
DNA may become straight during dynamics. Thirty Na1 are then added to
neutralize the system. Minimization follows using 50 steps of SD and 5000
steps of CG with a 50.0 kcal/mol restraint only on DNA. The 12 DNA
systems undergo fewer steps of equilibration stages because these systems
have less solvent than those of the TATA/TBP complex systems. The
numbers of equilibration steps are: 10,000 (heating), 20,000 (constant
pressure simulation I), 20,000 (constant pressure simulation II), and 20,000
(ﬁnal equilibration). More steps of production dynamics (1,600,000) were
used to allow the bent DNA to become stable. The length of each TATA
DNA trajectory is 3.34 ns.
Molecular mechanics Poisson-Boltzmann surface
area (MM-PBSA) free energy analyses
Molecular mechanics Poisson-Boltzmann surface area (MM-PBSA) (39–42)
is a free energy evaluation methodology that has been employed in a variety
of applications (see Discussion). The MM-PBSA free energy is estimated
from molecular mechanical energy EMM, solvation free energy GSOL, and
vibrational, rotational, and translational entropies S,
G ¼ EMM1GSOL  TS; (1)
EMM ¼ Eint1Evdw1Eele; (2)
GSOL ¼ Gpb1Gnp; (3)
where T is the temperature; Eint is internal energy, Eint ¼ Ebond 1 Eangle 1
Edihedral, the sum of bond, angle, and dihedral energies; Evdw is van der
Waals energy; Eele is electrostatic energy; Gpb is the electrostatic solvation
free energy, computed from the ﬁnite difference Poisson-Boltzmann method
in the DelPhi program (43,44); Gnp is nonpolar solvation free energy, Gnp ¼
gSASA 1 b, g ¼ 0.00542 kcal/A˚2, b ¼ 0.92 kcal/mol, and SASA is the
solvent-accessible surface area, which is estimated using Sanner’s algorithm
implemented in the MSMS software (45); and the solute entropy S is
approximated with normal mode analysis (46) using the Nmode module in
AMBER 7 (47). The MM-PBSA free energy computations are conducted in
AMBER 7 (47).
Binding free energies can be computed from triplet-trajectory analysis or
single-trajectory analysis. Triplet-trajectory analysis involves computing
free energies for the complex (TATA/TBP) as well as for the free ligand
(TATA DNA) and the free receptor (TBP) after they are simulated,
respectively (three trajectories); the respective binding free energy is the free
energy of the complex minus the free energies of the free ligand and the free
receptor. This method is theoretically accurate but computationally expen-
sive. Single- rather than triplet-trajectory analysis only uses the trajectory of
the complex; the binding free energy is thus expressed as the free energy of
the complex minus the free energies of the bound ligand and the bound
receptor in the complex. This method is faster but does not consider possible
ligand and receptor conformational changes going from their free states to the
bound states. We employ both methods for proper assessment. In addition,
we employ a computationally inexpensive analysis method by calculating
only the local molecular mechanics interaction energies between the TATA
DNA and TBP residues that are within 5 A˚ from the carcinogen.
Triplet-trajectory analysis
For each TATA/TBP complex and for the free TBP, the last 600-ps
trajectory of the production dynamics stage is used for free energy analyses:
60 snapshots at a 10-ps interval for computation of enthalpy (H ¼ EMM 1
GSOL) and 10 snapshots at 60-ps interval for computation of entropy. For
each free TATA DNA, the last 1600-ps trajectory of the production
dynamics stage is used for free energy analyses: 80 snapshots at a 20-ps
interval for computation of enthalpy and 10 snapshots at a 160-ps interval for
computation of entropy. The normal mode entropy analyses are estimates
and computationally expensive, so only 10 snapshots are selected for the
analyses. (With 50 snapshots for the unmodiﬁed DNA system, we obtained
the nearly identical entropy as in the 10-snapshot analysis; therefore we
use the more computationally feasible 10-snapshot entropy analysis for
all systems.)
Single-trajectory analysis
For each TATA/TBP complex and its bound TATA DNA and bound TBP,
the last 600-ps trajectory of the production dynamics stage of the complex
is used for free energy analyses: 60 snapshots at a 10-ps interval for
computation of enthalpy and 10 snapshots at 60-ps interval for computation
of entropy.
Temperature T is set to 277.15 K to mimic the experimental temperature
(27). For calculating EMM, the dielectric constant is set to 1.0. For cal-
culating GSOL, the salt concentration is set to 0.13 M to mimic the exper-
imental ionic strength (27); the internal dielectric constant is set to 1.0 and
external to 80.0. For calculating entropy, each structure is minimized using
the conjugate gradient method with a distance-dependent dielectric constant
(e ¼ 4R, where R is the interatomic distance) until the root-mean-square of
the elements in the gradient vector was ,104 kcal/mol/A˚. Its entropy is
then computed and averaged on all the 10 minimized structures.
RESULTS
Structural changes of TATA/TBP complex due to
BP modiﬁcations
In our previous study (7), we ranked the structural distortions
of the TATA DNA backbones and the TBP backbones of the
BP-modiﬁed systems compared to the unmodiﬁed one as
follows: minimal distortions for the 10R() stereoisomer at
A1, moderate distortion for the 10S(1) stereoisomer at A1,
and greatest distortions for the two stereoisomers at A2. We
also interpreted this adduct-location-dependent effect in
terms of conformational freedom and major-groove space
available to BP due to the hydrogen bonds and phenylalanine
insertions at the TATA/TBP interface: at A2, BP cannot
easily intercalate between the DNA bases and has a smaller
space in the DNA major groove (7).
To examine the speciﬁc BP-induced structural changes
of the TATA/TBP complex, we visualize these changes by
superimposing each BP-modiﬁed complex on the unmodi-
ﬁed one in Fig. 2. The structural changes are summarized in
Table 4. These structural changes are consistent with our
RMSD analyses (7): BP at A2 distorts the TATA/TBP
complex, while BP at A1 nearly conserves the complex, and
agree with the experimental ﬁnding (27) that BP at A2
decreases the TATA/TBP binding afﬁnity while BP at A1
slightly increases the binding afﬁnity. The slight increase
of binding afﬁnity by BP at A1 suggests that the ease of
intercalation by BP at A1 increases the stacking energy in the
severely bent TATA DNA and stabilizes the overall binding
between TATA and TBP. (Although we remodeled the DNA
sequence and our systems had limited simulation time, BP
has been stabilized early in simulations in all BP-modiﬁed
systems; in Appendix S3 in the Supplementary Material,
BP’s three torsion angles (x, a9, b9) as a function of
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simulation time are plotted for the ﬁrst BP-modiﬁed system
10S(1)-trans-(A1): II.)
Stereochemical effect of BP at A1
on TATA/TBP binding
The experimental work (27) showed that the TATA/TBP
binding afﬁnity changes are also dependent on the stereo-
chemistry of the BP-adenine adducts (Table 1). Of the two
adducts, the 10R() stereoisomer gives more favorable
binding afﬁnity changes than the 10S(1) stereoisomer at
both A1 and A2. However, as shown here, it is difﬁcult for BP
at A2 to adopt either the intercalated orientation or the major-
groove orientation. Thus, we interpret here the stereochem-
istry-dependent effect of BP at A1 on TATA/TBP binding.
BP at A1 can adopt both the intercalated orientation and
major-groove orientation. In the former arrangement, the
hydrophobic pyrenyl moiety of BP is buried between DNA
FIGURE 2 Superimposition of BP-modiﬁed and unmodiﬁed TATA/TBP complexes. Both structures are averaged over the last 600 ps of production
dynamics. The DNA strands are blue and green in the BP-modiﬁed complex and orange in the unmodiﬁed complex; the BP-adenine adduct is pink; TBP
residues are not shown except four phenylalanines; the four phenylalanines are red in the BP-modiﬁed complex and orange in the unmodiﬁed complex;
hydrogens are not shown. The two phenylalanines (Phe-162 at the second left and Phe-71 at the second right) insert and kink the DNA at A6 (A1) and A22 (A2);
the other two phenylalanines reside over T11 and A27 and are stabilized by van der Waals interactions. (A) 10S(1)-trans-(A1): II versus unmodiﬁed. (B)
10S(1)-trans-(A1): III versus unmodiﬁed. (C) 10R()-trans-(A1): II versus unmodiﬁed. (D) 10R()-trans-(A1): III versus unmodiﬁed. (E) 10R()-trans-(A1):
IV versus unmodiﬁed. (F) 10S(1)-trans-(A2): III versus unmodiﬁed. (G) 10S(1)-trans-(A2): III-2 versus unmodiﬁed. (H) 10S(1)-trans-(A2): IV versus
unmodiﬁed. (I) 10R()-trans-(A2): I versus unmodiﬁed. (J) 10R()-trans-(A2): III versus unmodiﬁed. (K) 10R()-trans-(A2): IV versus unmodiﬁed.
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bases and forms favorable stacking interactions between the
aromatic moiety and DNA bases; in the latter orientation,
the hydrophobic moiety will be exposed to the hydrophilic
solvent-accessible major groove. Thus the intercalated
orientation is favored and represents the major population
in the BP-modiﬁed TATA/TBP complex solution. This is
also consistent with the experimental result that BP at A1
slightly increases TATA/TBP binding (due to the favorable
stacking interaction in the intercalated orientation).
High-resolution NMR solution studies (23,24,26) show
that intercalated BP resides on the 39-side of the modiﬁed
adenine in the 10S(1) adduct and on the 59-side in the
10R() adduct. This agrees with our simulations of the two
systems with BP at A1 adopting the intercalated orientation:
10S(1)-trans-(A1): II (Fig. 2 A) and 10R()-trans-(A1): III
(Fig. 2 D).
We diagram the positions of the two stereoisomeric
adducts in Fig. 3; the 10S(1) BP intercalates between DNA
residues T27 and A26 (A2), and the 10R() BP between A28
and T27. We also diagram the major TATA/TBP interactions
in the ﬁgure for interpreting the stereochemistry-dependent
effect. The major interactions between TBP and the TATA
box include hydrogen bonds and phenylalanine insertions com-
puted from the last 600-ps production dynamics simulation
TABLE 4 Structural changes of TATA/TBP complex due to BP modiﬁcations
System Fig.
Phenylalanines* of
TBP TATA DNA BP
10S(1)-trans-(A1): II 2 A Phe-162
y is pushed
back to TBP by
1.65 A˚; the rest are
stable.
Backbone in the TATA region is pushed
toward TBP; the remaining part
remains stable.
Hydroxyls are in the solvent-accessible DNA
major groove; hydrophobic aromatic rings are
intercalated between DNA bases.
III 2 B All stable. Backbone in the TATA region is pushed
slightly toward TBP; the remaining
part remains stable.
Exposed to the solvent-accessible DNA major
groove.
10R()-trans-(A1): II 2 C All stable. Backbone is reserved; all TATA residues
(except A1) are positionally identical
with those from the unmodiﬁed
system.
Exposed to the solvent-accessible DNA major
groove.
III 2 D All stable. Backbone in the TATA region is pushed
slightly toward TBP; the remaining
part remains stable.
Hydroxyls are in the solvent-accessible DNA
major groove; hydrophobic aromatic rings are
intercalated between DNA bases.
IV 2 E All stable. Backbone is perfectly conserved; all
TATA residues (except A1) are
positionally similar to those from the
unmodiﬁed system.
Exposed to the solvent-accessible DNA major
groove.
10S(1)-trans-(A2): III 2 F All pushed back to
TBP.
Backbone is distorted. Hydroxyls are in the solvent-accessible DNA
major groove; hydrophobic aromatic rings are
partly intercalated between DNA bases.
III-2 2 G All moved slightly. Backbone is severely distorted. Hydroxyls are in contact with the central TATA
box; hydrophobic aromatic rings are in the
DNA major groove, but are close to the
beginning of the TATA box.
IV 2 H All pushed back to
TBP.
Backbone around A2 is distorted; back
bone in the TATA region is pushed
slightly toward TBP.
Hydroxyls are in the solvent-accessible DNA
major groove; hydrophobic aromatic rings are
distorted.
10R()-trans-(A2): I 2 I Phe-162 is pushed
back to TBP by
1.88 A˚; the rest are
moved slightly.
Backbone is distorted; A2 is largely
stretched to allow bulky BP to stay in
DNA major groove.
Exposed to the solvent-accessible DNA major
groove.
III 2 J Phe-162 is pushed
back to TBP by
1.32 A˚; the rest are
slightly pushed
back toward TBP.
Backbone is slightly distorted; thymine
(downstream of A1) loses its Watson-
Crick hydrogen bonds.
Exposed to the solvent-accessible DNA major
groove; the only system in which BP’s
orientation changes during MD: from
intercalated to major-groove form.
IV 2 K All moved slightly. Backbone is distorted, especially at the
A2 residue; thymine (downstream of
A1) loses its Watson-Crick hydrogen
bonds; glycosidic torsion x of the
thymine (upstream of A2) is rotated by
23.7.
Exposed to the solvent-accessible DNA major
groove.
*Referring to the four phenylalanines that interact with the TATA DNA and are shown in red in Fig. 2.
yReferring to the phenylalanine that inserts the ﬁrst basepair step of the TATA box.
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of the unmodiﬁed TATA/TBP complex (7). The two
phenylalanines kink the DNA at A6 (A1) and A22.
For the 10S(1) BP, the bulky aromatic rings intercalating
between the bases of T27 and A26 (A2) require more space
between these two bases. Thus the bases of T27 and A26 are
pushed to their 39 side and 59 side, respectively. T27’s base
lacks hydrogen bonds with TBP or with its 39-side neighbor
A28’s base; thus T27’s base has the ﬂexibility required to be
pushed to its 39 side. A26’s base has no hydrogen bonds with
TBP either but its 59-side neighbor T25’s base has one,
making the pushing of A26’s base to its 59 side relatively
difﬁcult. For the 10R() BP between A28 and T27, the
intercalation is relatively easy. A28’s base has no hydrogen
bonds with TBP and neither do its 39-side neighbors (outside
the 8-bp TATA box; not diagramed); thus A28’s base can
be pushed to its 39 side. T27’s base also has some ﬂexibility
to be pushed to its 59 side because T27’s base or its 59-side
neighbor (A26’s base) has no hydrogen bonds with TBP.
Thus, we have interpreted the stereochemistry-dependent
of BP at A1 in terms of the ﬂexibility of the TATA bases that
frame the intercalated adduct due to the hydrogen bonds
between the TATA box and TBP. It is relatively more easy
for the 10R() BP to adopt the intercalated orientation than
the 10S(1) BP, as found experimentally (Table 1). Note that
the above analysis does not consider the Watson-Crick hydro-
gen bonds, as each basepair in the TATA box maintains two.
Although the binding afﬁnity difference due to the stereo-
chemistry is very small (10.30 vs.10.47 kcal/mol; see the
binding free energies in Table 1), our simulations together
with structural analyses have helped interpret the small
stereochemistry-dependent effect of BP modiﬁcation at A1
on TATA/TBP binding.
Binding free energy analyses
The experimental binding free energies are derived from the
experimental equilibrium constants (27) and listed in Table
1. The derivation procedure is described in Appendix S4
in the Supplementary Material. We compute the theoretical
binding afﬁnities from our MD trajectories mainly using the
following two methods: triplet-trajectory analysis and single-
trajectory analysis. The other method (local molecular
mechanics interaction analysis) yields large variations in
the interaction energies (Appendix S5 in the Supplementary
Material) and is thus unable to interpret the global binding
afﬁnity differences shown in Table 1.
Triplet-trajectory analysis
Analyses based on separate trajectories are theoretically
more accurate for deriving binding free energies, since the
conformational changes of the TATA/DNA and TBP upon
binding are considered. Although the free TBP and DNA are
initially taken from the complexes (see Methods), their free
energies have stabilized during the simulation time in which
the free energies are computed, as shown in Appendix S6 in
the Supplementary Material. Table 5 shows the free energies
G(TATA/TBP) of TATA/TBP complexes, free energies
FIGURE 3 Diagram of major TATA/TBP interac-
tions and possible intercalation orientations of BP at A1
(A6). The TATA box residues are shown in gray, with
A6 (A1) and A26 (A2) highlighted in blue and green,
respectively. Each DNA residue is represented by one
horizontal bar as backbone and one vertical bar as base.
The major TATA/TBP interactions include hydrogen
bonds (white H letters on red background) and phenyl-
alanine insertions (white PHE letters on red back-
ground). Possible intercalation orientations of BP at A1
(A6) are shown with dashed boxes, and the stereochem-
istry of the BP-adenine adducts (10S(1), 10R()) are
labeled in the dashed boxes. The relatively weak interac-
tions (hydrophobic interactions and water-mediated hy-
drogen bonds) are not diagramed.
TABLE 5 Binding free energies from triplet-trajectory analysis
System G(TATA/TBP) G(TATA) DG DDG
Unmodiﬁed 15176 6 44 7008 6 23 34 6 58 0
10S(1)-trans-(A1): II 15086 6 41 6942 6 20 10 6 55 124
III 15108 6 32 6952 6 21 22 6 49 112
10R()-trans-(A1): II 15087 6 40 6942 6 20 11 6 54 123
III 15130 6 40 6957 6 19 39 6 54 5
IV 15069 6 41 6929 6 23 6 6 56 128
10S(1)-trans-(A2): III 15143 6 34 6971 6 20 38 6 50 4
III-215123 6 38 6964 6 22 25 6 53 19
IV 15103 6 45 6979 6 21 10 6 58 144
10R()-trans-(A2): I 15101 6 40 6930 6 23 37 6 55 3
III 15131 6 44 6953 6 22 44 6 58 10
IV 15110 6 42 6956 6 19 20 6 55 14
G(TATA/TBP) is the free energy of a TATA/TBP complex, G(TATA) is
the free energy of corresponding free TATA DNA, DG is the binding free
energy between TBP and TATA DNA, and DDG is the relative binding free
energy of a BP-modiﬁed TATA/TBP complex compared to the unmodiﬁed
one. The free energy of free TBP G(TBP) is 8134 6 30 kcal/mol. Under-
lined are the lowest energy in each of the four combinations of carcinogen
location (A1 or A2) and stereochemistry (10S(1) or 10R()). All energies
have the unit of kcal/mol and are shown in both average and standard
deviation (except DDG).
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G(TATA) of corresponding free TATA DNA, free energy
G(TBP) of free TBP, binding free energies DG between
TATA DNA and TBP, and relative binding free energies
DDG of the BP-modiﬁed TATA/TBP complexes compared
to the unmodiﬁed complex. We see that the DG values are
dominated by G(TATA/TBP) and have relative binding free
energies DDG ranging from 10 to 44 kcal/mol. The DDG
values are within the standard deviations of DG (49–58
kcal/mol), which means all systems have nearly the same
binding free energy. This agrees with the experimental bind-
ing free energies that have less than 1 kcal/mol differences
(Table 1). However, the computed standard deviations are
also too large to distinguish the binding free energies from
one another.
Single-trajectory analysis
Table 6 provides the results from the single-trajectory
analysis. The molecular mechanics energy changes DEMM
are dominated by the electrostatic energy changes DEele, and
the solvation free energy changes DGSOL are dominated by
the electrostatic solvation free energy changes DGpb. The
binding free energies DG are not dominated by any one term,
and their standard deviations (12–18 kcal/mol) are much
smaller than those from the triplet-trajectory analysis (49–58
kcal/mol; Table 5). Most DDG values are within the standard
deviations of DG. If we consider only the systems that have
the lowest relative binding free energy (underlined in the last
column of Table 6) in each of the four combinations of
adduct location (A1 or A2) and stereochemistry (10S(1) or
10R()), their relative binding free energies are much closer
(7, 7, 5, and 10 kcal/mol) and well within their standard
deviations. This small spread in magnitude is consistent
with the experimental binding free energy differences (,1
kcal/mol; Table 1).
Therefore, both the triplet-trajectory analysis and the
single-trajectory analysis reproduce the experimental relative
binding free energies within the computed standard devia-
tions. However, these standard deviations are large espe-
cially in the (theoretically more accurate) triplet-trajectory
analysis. We analyze this problem in details in Discussion.
DISCUSSION
Geacintov and co-workers (27) have shown that TATA/TBP
binding afﬁnity is altered with a bulky BP present in the
TATA box and that the binding afﬁnity decreases or slightly
increases depending on the location and stereochemistry of
the BP-adenine adduct. Although the changes of binding
afﬁnity are ,1.0 kcal/mol, our MD studies help interpret
such small changes in terms of conformational freedom and
major-groove space available to BP due to the hydrogen
bonds and phenylalanine insertions at the TATA/TBP inter-
face. That is, our structural and ﬂexibility analyses revealed
that BP at A2 has difﬁculty to adopt either intercalated or
major-groove orientation without distorting the TATA and
TBP backbones. For BP at A1, both orientations are easily
adopted. Furthermore, the 10R() stereoisomer at A1 can
more easily adopt the intercalated orientation due to the
larger ﬂexibility of the two DNA bases, between which the
BP is intercalated (BP in the 10R() stereoisomer thus has
larger conformational freedom). Thus, MD simulations,
together with structural analyses, help relate atomic-level
structure/ﬂexibility effects to global binding effects.
MM-PBSA has been applied to studying binding free
energies between protein and small ligand (48–57), protein
TABLE 6 Binding free energies from single-trajectory analysis
System DEele DEvdw DEMM DGnp DGpb DGSOL DH TDS DG DDG
Unmodiﬁed 6721 6 108 199 6 6 6920 6 107 11 6 0.4 6793 6 98 6782 6 98 138 6 11 67 6 13 71 6 17 0
10S(1)-trans-(A1): II 6540 6 79 197 6 6 6737 6 80 11 6 0.3 6609 6 83 6598 6 83 139 6 17 75 6 6 64 6 18 7
III 6472 6 78 201 6 7 6672 6 81 11 6 0.3 6554 6 74 6543 6 74 129 6 10 77 6 14 52 6 18 19
10R()-trans-(A1): II 6579 6 62 199 6 5 6777 6 62 11 6 0.3 6656 6 56 6645 6 56 132 6 9 78 6 9 54 6 13 17
III 6508 6 79 205 6 6 6713 6 82 11 6 0.3 6591 6 76 6580 6 76 133 6 8 69 6 10 64 6 18 7
IV 6599 6 74 198 6 7 6797 6 74 11 6 0.3 6676 6 68 6665 6 68 132 6 9 70 6 8 62 6 12 9
10S(1)-trans-(A2): III 6566 6 128 198 6 7 6764 6 131 11 6 0.3 6642 6 119 6631 6 119 133 6 14 70 6 6 63 6 15 8
III-26471 6 152 202 6 7 6673 6 154 11 6 0.4 6551 6 138 6540 6 138 133 6 17 67 6 5 66 6 18 5
IV 6589 6 76 201 6 7 6790 6 78 11 6 0.4 6670 6 71 6659 6 71 131 6 10 76 6 10 55 6 14 16
10R()-trans-(A2): I 6534 6 90 197 6 5 6731 6 90 11 6 0.2 6607 6 83 6596 6 83 135 6 10 74 6 7 61 6 12 10
III 6656 6 62 194 6 7 6850 6 61 11 6 0.4 6733 6 57 6712 6 57 138 6 8 83 6 11 55 6 14 16
IV 6588 6 75 209 6 6 6797 6 77 12 6 0.4 6679 6 70 6667 6 70 130 6 10 75 6 15 55 6 18 16
DEele, DEvdw, and DEint (zeros; not shown) are electrostatic energy, van der Waals energy, and internal energy changes. DEMM is the molecular mechanics
energy change and DEMM ¼ DEele 1 DEvdw 1 DEint. Gnp and DGpb are nonpolar and electrostatic solvation free energy changes. DGSOL is solvation free
energy change and DGSOL ¼ DGnp 1 DGpb. DH is enthalpy change and DH ¼DEMM 1 DGSOL. T is the absolute temperature and DS is the entropy change.
DG is the binding free energy and DG ¼ DEMM 1 DGSOL  TDS. DDG is the relative binding free energy of a BP-modiﬁed system compared to the
unmodiﬁed one. Underlined are the lowest energy in each of the four combinations of carcinogen location (A1 or A2) and stereochemistry (10S(1) or
10R()). All energies have the unit of kcal/mol and are shown in both average and standard deviation (except DDG). Although DH ¼DEMM 1 DGSOL, the
large standard deviations of DEMM and DGSOL do not lead to large standard deviations of DH, which means ﬂuctuations of these two terms are mostly
canceled out.
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and protein (58–62), protein and peptide (63,64), small
molecule and small molecule (65,66), RNA and peptide (67),
RNA and small ligand (68), DNA and small ligand (69), and
protein and RNA (70). To the best of our knowledge, our
case is the ﬁrst MM-PBSA binding free energy study be-
tween protein and DNA. Though our free energy calcula-
tions reproduce the experimental relative binding free
energies within the computed standard deviations, these
standard deviations are large, especially in the theoretically
more accurate triplet-trajectory analysis, which considers the
conformational changes of the ligand (TATA DNA) and the
receptor (TBP) upon binding. Wang and co-workers under-
score several sources of error in MM-PBSA: the force ﬁeld,
MD sampling, solvation free energy estimate of PBSA, and
the entropy estimated by normal mode analyses (54). They
also suggest that the MM-PBSA approach may not work as
well in calculating the absolute binding free energy for
charged ligands as for neutral systems (54). In the following,
we focus on discussing the two error sources—MD sampling
and electrostatic solvation free energy.
Although experimental results are condition-dependent,
they are averaged in time and space for many molecular sys-
tems. In contrast, a MD trajectory only mimics behavior of
one molecule within a limited time span in the large thermally
accessible conformation space. This causes large standard
deviations in the free energy evaluation. Fig. 4 shows relative
TATA/TBP electrostatic interaction energies of four BP-
modiﬁed systems compared to the unmodiﬁed one. The wide
variations of interactions between the TBP residues and the
TATA/DNA indicate that there are large random movements
by the ﬂexible TBP residues. Large ﬂuctuations in binding
free energies are also reported in a recent protein-ligand
association free-energy study by Swanson and co-workers
(53). These ﬂuctuations explain why freezing the atoms
outside binding regions yields good binding free energies for
large systems (54,56). Without freezing, two trajectories for
the same molecule may produce two quite different binding
free energies. For example, one trajectory of our 10S(1)-
trans-(A2): III complex produces a63 kcal/mol binding free
energy and another gives 75 kcal/mol, although they are
within the standard deviations of 15 kcal/mol. (Please note
that freezing may not be appropriate if the frozen parts should
undergo conformational changes upon binding.) Increasing
MD sampling to overcome large energy ﬂuctuations remains
difﬁcult due to the high cost of MD simulations and free-
energy analyses of large systems.
The electrostatic solvation free energy Gpb (main part
of solvation free energy) obtained by solving the Poisson-
Boltzmann equation (PBE) is another large error source in
MM-PBSA. One reason is that the implicit treatment of water
and counterions in the PBE is still a step away from describing
the atomic-level explicit solvent environment. Wagoner and
Baker ﬁnd that polar solvation forces generated by PBE
systematically overestimate the magnitude of the explicit
solvent forces (71) (their work also shows that SASA-based
nonpolar forces have no signiﬁcant correlation with nonpolar
explicit solvent forces). Another reason stems from uncertainty
regarding dielectric constants. The solute dielectric constant
ein, which we set to its vacuum value of 1.0, can vary over a
wide range (1.0–20.0) according to different studies (discussed
in (72)). However, the variation in ein has a dramatic effect on
the electrostatic solvation free energies Gpb. For example, Gpb
of our 10R()-trans-(A1): III complex is 8518 kcal/mol if
ein¼ 1.0, and2019 kcal/mol if ein¼ 4.0. In a comprehensive
review (73), Schutz and Warshel conclude that the dielectric
constant is not a universal constant but a parameter that
depends on the model used. The more explicit the model, the
smaller the dielectric constant that is needed. The dielectric
constant can be as small as 1.0 if all contributions are treated
explicitly and accurately, including protein permanent dipole,
protein reorganization energy, and water penetration, etc. We
also note that the solvent dielectric constant eout, which we set
to 80, is dependent on temperature (74).
In sum, developing a more accurate and faster free energy
calculation method still is a distance away. Our TATA/TBP
systems are both large (211 residues) and highly charged
(30 e on the DNA), which makes our systems difﬁcult for
binding free-energy evaluation. The large standard devia-
tions may also be partly caused by the limited trajectories
and timescales in our simulations (one 2.32-ns trajectory for
each of the 12 TATA/TBP complexes and the free TBP; one
3.34-ns trajectory for each of the 12 free TATA DNA) due to
the large set and sizes of the systems and limited computing
FIGURE 4 Relative electrostatic interaction energies of TBP residues
with TATA DNA. Each spot indicates the relative TBP residue/DNA elec-
trostatic interaction energy of a carcinogen-modiﬁed system compared to the
unmodiﬁed one (noCar). The four carcinogen-modiﬁed systems are 10S(1)-
trans-(A1): III (A1pIII); 10R()-trans-(A1): III (A1mIII); 10S(1)-trans-
(A2): III (A2pIII); and 10R()-trans-(A2): III (A2mIII). The energies are
averaged over the last 600 ps of production dynamics. The TBP residues are
listed in six groups separated by vertical lines: positively charged (11 e)
lysine (LYS); positively charged (11 e) arginine (ARG); neutral histidine
(HID); negatively charged (1 e) aspartic acid (ASP); negatively charged
(1 e) glutamic acid (GLU); and the rest are residues. All the groups, except
the last one, are also provided with residue numbers.
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resources available. Still, despite these limitations, both the
triplet-trajectory analysis and the single-trajectory analysis
produce the relative binding free energies (Table 5 and Table
6) consistent with the experimental values (Table 1) within
the computed standard deviations. Thus, structurally distinct
molecules may have similar binding free energies. The single-
trajectory analysis (Table 6) yields much smaller standard
deviations than the triplet-trajectory analysis (Table 5)
because fewer random movements (Fig. 4) are introduced
in the former, which actually only calculates the interactions
at the TATA/TBP interfaces. This is similar to the case in
which freezing the atoms outside the binding regions can
give better binding free energies for large systems (54,56).
Therefore, besides improvements in the MM-PBSA meth-
odology, future binding free energy calculations of DNA/
protein complexes require longer simulation time, multiple
trajectories for each system, and restraints on noninterface
residues (if they do not undergo conformational changes
upon binding). Employing multiple trajectories for each
system can also help to identify the timescale limitation on a
system due to the deﬁciencies in force ﬁelds and simulation
protocols (75,76).
CONCLUSION
This study reveals the speciﬁc position and stereochemistry-
dependent structural changes of the TATA/TBP complex
due to BP binding to the TATA box. Together with our
former analyses (7), we can interpret the location-dependent
effect and stereochemistry-dependent effect (for BP at A1) of
BP modiﬁcations on TATA/TBP binding in terms of the
conformational freedom and major-groove space available to
BP due to the hydrogen bonds and phenylalanine insertions
at the TATA/TBP interface. Thermodynamic analyses using
MM-PBSA produce large standard deviations, which make
the computed binding free energies the same within the error
bars. Although it agrees with the experimental binding free
energy differences (,1 kcal/mol), it suggests the need for
MM-PBSA methodology improvements and better sampling
for evaluating binding free energies of large and highly
charged systems like DNA/protein complexes. More gener-
ally, the unraveled structures and interactions in these studies
can help investigate how transcription initiation may be
affected by a bulky BP chemically binding to the TATA box.
APPENDIX: PROCEDURE OF COMPUTING
PARTIAL CHARGES OF CARCINOGEN-MODIFIED
B-DEOXYNUCLEOTIDES
Step 1: Build two molecules (InsightII)
To make our partial charges compatible with AMBER’s force ﬁeld (29), we
calculate partial charges of the following two molecules, similar to the way
AMBER (34) does. Finally we will combine the partial charges of these two
molecules in Step 5. We use InsightII (Accelrys) to build these two
molecules.
Nucleoside with carcinogen
HO59-O59 ðIIIÞ
j
sugar-base-carcinogen
j
O39-HO39ðIÞ
Cap 59 and 39-end (no phosphate group).
Set dihedral angles:
bðHO59-O59-C59-C49Þ ¼ 180:0
eðC49-C39-O39-HO39Þ ¼ 180:0
gðO59-C59-C49-C39Þ ¼ 58:5ðDA; DA5; DA3Þ
¼ 58:9ðDC; DC5; DC3Þ
¼ 58:5ðDG; DG5; DG3Þ
¼ 58:4ðDT; DT5; DT3Þ
No bumps.
Dimethylphosphate (DMP)
H O1P H
j j j
H-C--O39-P-O59--C-H
j j j
H O2P H
ðIIÞ ðIVÞ
Set dihedral angles:
CO39PO59 ¼ 73:1
O39PO59C ¼ 73:1
(Cieplak et al. (33) used positive dihedral angles. But in regular A- and
B-DNA, these dihedral angles are negative, i.e., (g, g) conformation.)
No bumps.
Step 2: Optimize geometry on each
molecule (Gaussian)
The geometry optimization of both molecules will be performed in next step
as the electrostatic potentials (ESP) are calculated simultaneously in
Gaussian (77). The time of Gaussian calculation with optimization option
will be quite long (;1 week) on the nucleoside with carcinogen. (The
optimized structures can be used for building topology ﬁles for AMBER, if
one needs to do molecular dynamics.) If you want to calculate the partial
charges on a speciﬁc structural conformation, you may skip this step.
Step 3: Calculate electrostatic potential (ESP) on
each molecule (Gaussian)
How to build Gaussian input ﬁles can be found in the Gaussian Manual (77).
Following are a few parameters which have to be set in Gaussian input ﬁles:
Route section (HF/6-31G*, ESP output, optimization; remove ‘‘opt’’ if
you want to calculate the partial charges on a speciﬁc structural
conformation): # HF/6-31G* pop ¼ (minimal,mk) opt maxdisk ¼
134217728 iop(6/33 ¼ 2).
Charge ¼ 0 (nucleoside with carcinogen, if carcinogen has zero charge),
or ¼ 1 (dimethylphosphate).
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Spin multiplicity ¼ Nup11 (Nup is the number of unpaired electrons;
ground state).
Step 4: Check interactions in optimized
structures (InsightII)
Gaussian does not know where bonds, angles, and dihedral angles are if
we do not tell in the input ﬁles. So the optimized structures may have
unreasonable interactions. We use InsightII to check bumps in the optimized
structures. If all the interactions are reasonable, we can go to next step.
Otherwise, we have to restart from Step 1 (or the current optimized
structures) by manually adjusting the structures to avoid further unreason-
able interactions.
Step 5: Calculate partial charges of both
molecules together (RESP)
Now we need to combine ESP of these two molecules to calculate the partial
charges of the carcinogen modiﬁed nucleotide within two stages of
AMBER’s RESP. See AMBER Manual (34) for how to build the input
ﬁles for RESP. The partial charges of the phosphate group (P, O1P, and
O2P) will be taken from the dimethylphosphate (DMP).
First stage
Charge constraints:
I 1 II ¼ 0 (DX5, X ¼ A, C, G, or T. Partial charge of O39 will be taken
from DMP), or III 1 IV ¼ 0 (DX3, Partial charge of O59 will be
taken from DMP), or I 1 II ¼ III 1 IV ¼ 0 (DX, Partial charges of
O39 and O59 will be taken from DMP).
O1P, O2P in phosphate group are equivalenced.
H in NH2 groups are equivalenced.
Hyperbolic restraints with a force constant a ¼ 0.0005 are applied to all
heavy atoms, and hydrogens are not restrained.
Second stage
CH2 and CH3 in nucleoside are reﬁt; other atoms’ charges are kept.
Hyperbolic restraints with a force constant a ¼ 0.001 are applied to only
the carbons of CH2 and CH3 in nucleoside, and hydrogens are not
restrained.
H in CH2 or CH3 in nucleoside are equivalenced.
Notes
The ﬁnal total charge of the carcinogen modiﬁed nucleotide will be exactly
1.0000 for DX types (X ¼ A, C, G, or T), if the carcinogen has zero
charge. This procedure can be easily applied to A-deoxynucleotides and
A-ribonucleotides with Cieplak et al. (33). PERL programs and a sample are
available at http://monod.biomath.nyu.edu/;qzhang/Research.htm.
SUPPLEMENTARY MATERIAL
An online supplement to this article can be found by visiting
BJ Online at http://www.biophysj.org.
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